Annual EBITDA
-$492.89M$312.91M-173.87%
Summary
- Current Value
- As of today, DNLI annual EBITDA is -$492.89M, down -173.87% on
- Historical Performance
- DNLI annual EBITDA is down -71.64% over the past 3 years, and down -140.21% over the past 5 years
- All-Time High Comparison
- DNLI annual EBITDA is currently -791.78% below its historical high of $71.25M set on
- 3-Year Low Comparison
- DNLI annual EBITDA is at its 3-year low
- Sector Comparison
- DNLI annual EBITDA is higher than 1.69% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$492.89M | -173.9% | -71.6% | -140.2% | -2876.7% | |
| Quarterly EBITDA | -$134.49M | -10.8% | -26.6% | -129.3% | -340.5% | |
| TTM EBITDA | -$537.65M | -8.3% | -74.9% | -132.4% | -1661.0% | |
| Price | $16.95 | -20.0% | -41.3% | -77.1% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $0.00 | -100.0% | -100.0% | -100.0% | 0.0% | |
| Annual EPS | -$2.57 | -143.1% | -7.5% | -24.4% | -1279.0% | |
| Annual EBIT | -$501.88M | -155.2% | -69.7% | -135.4% | -2909.0% | |
| Annual Net Income | -$422.77M | -191.1% | -45.5% | -113.9% | -2418.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$179.97M | -173.9% | |
| 5Y | $71.25M | N/A | -791.8% |
| All | $71.25M | -791.8% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$492.89M | at low | |
| 5Y | -$492.89M | at low | |
| All | -$492.89M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$492.89M | -173.9% | |
| -$179.97M | +45.5% | |
| -$330.36M | -15.0% | |
| -$287.16M | -503.0% | |
| $71.25M | +134.7% |
| Year | Value | Change |
|---|---|---|
| -$205.19M | -426.7% | |
| -$38.96M | +55.3% | |
| -$87.06M | -1.3% | |
| -$85.96M | -419.2% | |
| -$16.56M | - |
FAQ
What is the current annual EBITDA of DNLI?
As of today, DNLI annual EBITDA is -$492.89M
What is 1-year change in DNLI annual EBITDA?
DNLI annual EBITDA is down -173.87% year-over-year
What is 3-year change in DNLI annual EBITDA?
DNLI annual EBITDA is down -71.64% over the past 3 years
How far is DNLI annual EBITDA from its all-time high?
DNLI annual EBITDA is currently -791.78% below its historical high of $71.25M set on December 31, 2020
How does DNLI annual EBITDA rank versus sector peers?
DNLI annual EBITDA is higher than 1.69% of companies in Healthcare sector
When is DNLI next annual earnings release?
The next annual earnings release for DNLI is on
Quarterly EBITDA
-$134.49M$2.57M-1.95%
Summary
- Current Value
- As of today, DNLI quarterly EBITDA is -$134.49M, down -1.95% on
- Historical Performance
- DNLI quarterly EBITDA is down -10.83% year-over-year, and down -26.62% over the past 3 years
- All-Time High Comparison
- DNLI quarterly EBITDA is currently -154.78% below its historical high of $245.51M set on
- 3-Year Low Comparison
- DNLI quarterly EBITDA is +6.12% above its 3-year low of -$143.26M reached on
- Sector Comparison
- DNLI quarterly EBITDA is higher than 1.81% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$134.49M | -1.9% | -10.8% | -26.6% | -129.3% | |
| Annual EBITDA | -$492.89M | – | -173.9% | -71.6% | -140.2% | |
| TTM EBITDA | -$537.65M | -2.5% | -8.3% | -74.9% | -132.4% | |
| Price | $16.95 | +13.8% | -20.0% | -41.3% | -77.1% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $0.00 | 0.0% | 0.0% | -100.0% | -100.0% | |
| Quarterly EPS | -$0.74 | -1.7% | -16.4% | +12.0% | -35.9% | |
| Quarterly EBIT | -$137.43M | -1.8% | -11.6% | -27.9% | -128.6% | |
| Quarterly Net Income | -$126.90M | -2.2% | -18.4% | -22.9% | -117.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$127.99M | N/A | -5.1% |
| 3Y | $171.84M | -178.3% | |
| 5Y | $245.51M | N/A | -154.8% |
| All | $245.51M | -154.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$143.26M | +6.1% | |
| 3Y | -$143.26M | +6.1% | |
| 5Y | -$143.26M | +6.1% | |
| All | -$143.26M | +6.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of DNLI?
As of today, DNLI quarterly EBITDA is -$134.49M
What is DNLI quarterly EBITDA most recent change?
DNLI quarterly EBITDA was down -1.95% on September 30, 2025
What is 1-year change in DNLI quarterly EBITDA?
DNLI quarterly EBITDA is down -10.83% year-over-year
How far is DNLI quarterly EBITDA from its all-time high?
DNLI quarterly EBITDA is currently -154.78% below its historical high of $245.51M set on December 31, 2020
How does DNLI quarterly EBITDA rank versus sector peers?
DNLI quarterly EBITDA is higher than 1.81% of companies in Healthcare sector
When is DNLI next earnings release?
The next earnings release for DNLI is on
TTM EBITDA
-$537.65M$13.14M-2.50%
Summary
- Current Value
- As of today, DNLI TTM EBITDA is -$537.65M, down -2.50% on
- Historical Performance
- DNLI TTM EBITDA is down -8.29% year-over-year, and down -74.90% over the past 3 years
- All-Time High Comparison
- DNLI TTM EBITDA is currently -869.54% below its historical high of $69.87M set on
- 3-Year Low Comparison
- DNLI TTM EBITDA is at its 3-year low
- Sector Comparison
- DNLI TTM EBITDA is higher than 1.26% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$537.65M | -2.5% | -8.3% | -74.9% | -132.4% | |
| Annual EBITDA | -$492.89M | – | -173.9% | -71.6% | -140.2% | |
| Quarterly EBITDA | -$134.49M | -1.9% | -10.8% | -26.6% | -129.3% | |
| Price | $16.95 | +13.8% | -20.0% | -41.3% | -77.1% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $0.00 | 0.0% | 0.0% | -100.0% | -100.0% | |
| TTM EPS | -$2.91 | -3.7% | -5.3% | -18.2% | -31.3% | |
| TTM EBIT | -$547.82M | -2.7% | -8.6% | -75.3% | -129.1% | |
| TTM Net Income | -$498.74M | -4.1% | -16.7% | -64.8% | -119.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$494.08M | N/A | -8.8% |
| 3Y | -$148.13M | -263.0% | |
| 5Y | $69.87M | N/A | -869.5% |
| All | $69.87M | -869.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$537.65M | at low | |
| 3Y | -$537.65M | at low | |
| 5Y | -$537.65M | at low | |
| All | -$537.65M | at low |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of DNLI?
As of today, DNLI TTM EBITDA is -$537.65M
What is DNLI TTM EBITDA most recent change?
DNLI TTM EBITDA was down -2.50% on September 30, 2025
What is 1-year change in DNLI TTM EBITDA?
DNLI TTM EBITDA is down -8.29% year-over-year
How far is DNLI TTM EBITDA from its all-time high?
DNLI TTM EBITDA is currently -869.54% below its historical high of $69.87M set on December 31, 2020
How does DNLI TTM EBITDA rank versus sector peers?
DNLI TTM EBITDA is higher than 1.26% of companies in Healthcare sector
When is DNLI next earnings release?
The next earnings release for DNLI is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- DNLI Official Website www.denalitherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1714899/000171489925000193/0001714899-25-000193-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1714899/000171489925000066/0001714899-25-000066-index.htm
- DNLI Profile on Yahoo Finance finance.yahoo.com/quote/DNLI
- DNLI Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dnli